Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173,314 | 190,021 | 223,503 | 236,865 | 183,351 |
| Marketable Securities | 283,988 | 293,464 | 364,204 | 462,716 | 644,559 |
| TOTAL | $471,323 | $502,858 | $602,171 | $716,061 | $845,130 |
| Non-Current Assets | |||||
| PPE Net | 122,990 | 125,883 | 125,459 | 123,146 | 118,840 |
| Investments And Advances | 382,378 | 396,132 | 344,342 | 283,924 | 207,946 |
| Other Non-Current Assets | 74,137 | 54,373 | 54,752 | 55,913 | 55,913 |
| TOTAL | $579,505 | $576,388 | $524,553 | $462,983 | $382,699 |
| Total Assets | $1,050,828 | $1,079,246 | $1,126,724 | $1,179,044 | $1,227,829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,255 | 11,499 | 11,005 | 14,875 | 10,390 |
| Accrued Expenses | 37,496 | 41,626 | 34,688 | 39,735 | 44,938 |
| TOTAL | $47,907 | $53,490 | $45,998 | $54,849 | $94,320 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 156 | 365 | 305 | 239 | 38,992 |
| Other Non-Current Liabilities | 77,721 | 55,814 | 56,914 | 54,416 | 53,892 |
| TOTAL | $77,721 | $55,814 | $56,914 | $54,416 | $53,892 |
| Total Liabilities | $125,628 | $109,304 | $102,912 | $109,265 | $148,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 142,752 | 142,516 | 142,183 | 141,538 | 140,648 |
| Common Shares | 142 | 142 | 142 | 141 | 140 |
| Retained earnings | -894,554 | -828,480 | -750,294 | -679,358 | -646,343 |
| Other shareholders' equity | -2,567 | -398 | -334 | -101 | 268 |
| TOTAL | $925,200 | $969,942 | $1,023,812 | $1,069,779 | $1,079,617 |
| Total Liabilities And Equity | $1,050,828 | $1,079,246 | $1,126,724 | $1,179,044 | $1,227,829 |